| F-18-choline PET/MRI in suspected recurrence of prostate carcinoma |
5 |
| Next generation of radiotracers for sentinel lymph node biopsy: What is still necessary to establish new imaging paradigms? |
5 |
| Role of F-18-FDG PET/CT in establishing new clinical and therapeutic modalities in lung cancer. A short review |
4 |
| Association between white matter lesions and the cerebral glucose metabolism in patients with cognitive impairment |
3 |
| Intraindividual comparison of Ga-68-DOTATATE PET / CT vs C-11-Choline PET / CT in patients with prostate cancer in biochemical relapse: in vivo evaluation of the expression of somatostatin receptors |
3 |
| Comparative study of F-18-FDG PET/CT and CT angiography in detection of large vessel vasculitis |
3 |
| Improved diagnostic accuracy for myocardial perfusion imaging using artificial neural networks on different input variables including clinical and quantification data |
3 |
| Ga-68-PSMA PET/CT in prostate cancer |
3 |
| 67-Gallium SPECT/CT in febrile syndromes of unknown origin |
3 |
| Lymphoscintigraphic findings in patients with lipedema |
3 |
| Detection and quantification of Ra-223 uptake in bone metastases of patients with castration resistant prostate carcinoma, with the aim of determining the absorbed dose in the metastases |
3 |
| Tissue-muscle perfusion assessed by one day Tc-99m-MIBI rest-dipyridamol scintigraphy in non-diabetic and diabetic patients |
2 |
| Tc-99m-HMPAO brain SPECT in the monitoring of cerebral vasculitis therapy |
2 |
| Correlation between molecular tumor volume evaluated with Ga-68-PSMA PET/CT and prostatic specific antigen levels |
2 |
| Update of the role of Nuclear Medicine techniques in the pre-surgical localization of primary hyperparathyroidism |
2 |
| Comparison of four methods for quantitative assessment of Tc-99m-MDP SPECT in patients with suspected condylar hyperplasia |
2 |
| Clinical and prognostic value of F-18-FDG PET/CT in recurrent endometrial carcinoma |
2 |
| Review of the role of the sentinel node biopsy in neoadjuvant chemotherapy in women with breast cancer and negative or positive axillary node at diagnosis |
2 |
| Diagnostic impact of F-18-FDG PET/CT on the management of rare breast carcinomas: Apocrine and neuroendocrine carcinomas |
2 |
| Radioiodine treatment of differentiated thyroid cancer related to guidelines and scientific literature |
2 |
| A rare case of a I-123-MIBG SPELT/CT positive, but Ga-68-DOTA-TOC PET/CT negative pheochromocytoma of the bladder |
2 |
| Radium-223 in the treatment of bone metastasis in patients with castration-resistant prostate cancer. Review and procedure |
1 |
| Importance of Ga-68-PSMA PET/CT in hospital practice. View of the radiation oncologist |
1 |
| Can positron emission tomography support the characterization of immune-mediated inner ear disease? |
1 |
| Different uptake of I-123-MIBG in the two main liver lobes: A persistant unsolved mistery |
1 |
| Update on radioguided surgery: from international consensus on sentinel node in head and neck cancer to the advances on gynaecological tumors and localization of non-palpable lesions |
1 |
| PET/TC imaging with somatostatin analogues for assessment of neuroendocrine tumors, initial experience |
1 |
| Relationships between hypoxia induced factor-1 alpha and F-18-FDG PET/CT parameters in colorectal cancer |
1 |
| Technetium-99m-labeled lapachol as an imaging probe for breast tumor identification |
1 |
| F-18-FDG PET/CT in staging and delineation of radiotherapy volume for head and neck cancer |
1 |
| F-18-FDG PET/CT in a cardiac metastasis in a patient with history of malignant neuroectodermal tumour of the chest wall: Case report and review of the literature |
1 |
| Selective biopsy of the sentinel node in cancer of cervix: Experience in validation phase |
1 |
| C-11-PIB retention patterns in white and grey cerebral matter in idiopathic normal pressure hydrocephalus patients. A visual analysis |
1 |
| Predictive and prognostic potential of volume-based metabolic variables obtained by a baseline F-18-FDG PET/CT in breast cancer with neoadjuvant chemotherapy indication |
1 |
| Correlation of F-18-FDG uptake on PET/CT with Ki67 immunohistochemistry in pre-treatment epithelial ovarian cancer |
1 |
| Hepatobiliary scintigraphy in the study of complications in adult patients after liver transplant. Description of the experience |
1 |
| Ga-68-DOTATOC PET/CT in the localization of metastatic extra-adrenal paraganglioma and pheochromocytoma compared with F-18-DOPA PET/CT |
1 |
| Clinical usefulness of two-phase F-18-sodium-fluoride (F-18-NaF) bone PET/CT for evaluating treatment response of bone metastases from breast cancer: Case report |
1 |
| Role of F-18-FDG PET/CT in restaging and follow-up of patients with uterine sarcomas |
1 |
| Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer |
1 |
| Contralateral axillary sentinel lymph node drainage in breast cancer: Controversies and management according to the literature. A case report |
1 |
| Selective sentinel lymph node biopsy in male breast cancer |
1 |
| Contribution of C-11-Choline PET/CT in prostate carcinoma biochemical relapse with serum PSA level below 1 ng/ml |
1 |
| Cardiac F-18-FDG PET/CT procedure for the diagnosis of prosthetic endocarditis and intracardiac devices |
1 |
| Prognostic value of primary tumor SUVmax on pre-treatment F-18-FDG PET/CT imaging in patients with stage III non-small cell lung cancer |
1 |
| Characterization and simulation of noise in PET images reconstructed with OSEM: Development of a method for the generation of synthetic images |
1 |
| Parameters of metabolic quantification in clinical practice. Is it now time to include them in reports? |
1 |
| Hybrid imaging in foot and ankle disorders |
1 |
| Concordance between brain F-18-FDG PET and cerebrospinal fluid biomarkers in diagnosing Alzheimer's disease |
1 |
| Efficacy of early imaging with Ga-68-PSMA-I&T in the discrimination of pelvic lesions in prostate cancer patients |
1 |
